DE59302329D1 - Mikroverkapselung wasserlöslicher Wirkstoffe - Google Patents

Mikroverkapselung wasserlöslicher Wirkstoffe

Info

Publication number
DE59302329D1
DE59302329D1 DE59302329T DE59302329T DE59302329D1 DE 59302329 D1 DE59302329 D1 DE 59302329D1 DE 59302329 T DE59302329 T DE 59302329T DE 59302329 T DE59302329 T DE 59302329T DE 59302329 D1 DE59302329 D1 DE 59302329D1
Authority
DE
Germany
Prior art keywords
active ingredients
microencapsulation
water
soln
soluble active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59302329T
Other languages
English (en)
Inventor
Birgit Dr Nerlich
Reinhard Dr Mank
Jan Dr Gustafsson
Joachim Hoerig
Wolfgang Dr Koechling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring GmbH
Original Assignee
Ferring Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Arzneimittel GmbH filed Critical Ferring Arzneimittel GmbH
Priority to DE59302329T priority Critical patent/DE59302329D1/de
Application granted granted Critical
Publication of DE59302329D1 publication Critical patent/DE59302329D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
DE59302329T 1992-07-10 1993-06-29 Mikroverkapselung wasserlöslicher Wirkstoffe Expired - Lifetime DE59302329D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59302329T DE59302329D1 (de) 1992-07-10 1993-06-29 Mikroverkapselung wasserlöslicher Wirkstoffe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4223169A DE4223169C1 (de) 1992-07-10 1992-07-10 Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
DE59302329T DE59302329D1 (de) 1992-07-10 1993-06-29 Mikroverkapselung wasserlöslicher Wirkstoffe

Publications (1)

Publication Number Publication Date
DE59302329D1 true DE59302329D1 (de) 1996-05-30

Family

ID=6463190

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4223169A Expired - Fee Related DE4223169C1 (de) 1992-07-10 1992-07-10 Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
DE59302329T Expired - Lifetime DE59302329D1 (de) 1992-07-10 1993-06-29 Mikroverkapselung wasserlöslicher Wirkstoffe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4223169A Expired - Fee Related DE4223169C1 (de) 1992-07-10 1992-07-10 Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe

Country Status (7)

Country Link
US (1) US5503851A (de)
EP (1) EP0579347B1 (de)
AT (1) ATE137114T1 (de)
DE (2) DE4223169C1 (de)
DK (1) DK0579347T3 (de)
ES (1) ES2085716T3 (de)
HK (1) HK1001470A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT729357E (pt) * 1993-11-19 2005-06-30 Janssen Pharmaceutica Nv 1,2-bwenzazoles microencapsulados
CA2190121A1 (en) 1994-03-15 1995-09-21 Edith Mathiowitz Polymeric gene delivery system
CA2224381A1 (en) 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
AU3981097A (en) * 1996-08-21 1998-03-06 Alkermes Controlled Therapeutics, Inc. Controlled release microparticles with a hydrophobic material
FR2762318B1 (fr) * 1997-04-18 1999-09-17 Pharma Biotech Compositions presentant une liberation prolongee et leur procede de preparation
AR012448A1 (es) 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
FR2776516B1 (fr) * 1998-03-25 2001-05-25 Pharma Biotech Compositions presentant une liberation prolongee et leur procede de preparation
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
ES2283936T3 (es) 1997-07-07 2007-11-01 Medical Research Council Procedimiento de clasificacion in vitro.
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
AU4724401A (en) 2000-02-28 2001-09-12 Genesegues Inc Nanocapsule encapsulation system and method
AU2001287349B2 (en) * 2000-09-01 2006-03-02 Palmaya Pty Ltd Slow release pharmaceutical preparation and method of administering same
WO2002049619A2 (en) 2000-12-21 2002-06-27 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophilic active agents
WO2002058671A1 (en) * 2001-01-26 2002-08-01 Debio Recherche Pharmaceutique S.A. Burst free pharmaceutical microparticules
WO2002094321A1 (fr) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
ES2427930T3 (es) * 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
GB0127564D0 (en) 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
ES2380893T3 (es) 2003-01-29 2012-05-21 454 Life Sciences Corporation Amplificación de ácidos nucleicos en emulsión en perlas
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
EP2918595B1 (de) 2003-07-05 2019-12-11 The Johns-Hopkins University Verfahren und Zusammensetzungen zur Detektion und Zählung von genetischen Variationen
ES2432040T3 (es) * 2004-01-28 2013-11-29 454 Life Sciences Corporation Amplificación de ácido nucleico con emulsión de flujo continuo
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP3913375A1 (de) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtungen und verfahren zur verwendung bei der bildung und steuerung von nanoreaktoren
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100015240A1 (en) * 2008-07-16 2010-01-21 Danielle Biggs Process for preparing microparticles containing bioactive peptides
EP4047367A1 (de) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
EP2486409A1 (de) 2009-10-09 2012-08-15 Universite De Strasbourg Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
EP3392349A1 (de) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digitale analyse von analyten
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP3447155A1 (de) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwichassays in tröpfchen
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3709018A1 (de) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtung zum nachweis von komponenten einer chemischen reaktion
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3090063B1 (de) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Verfahren zur detektion von latentem retrovirus
WO2015158823A1 (de) 2014-04-16 2015-10-22 Veyx-Pharma Gmbh Veterinärpharmazeutische zusammensetzung und deren verwendung
CN111700877A (zh) 2014-09-03 2020-09-25 吉倪塞思公司 治疗性纳米粒子和相关的组合物、方法和系统
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
IT202000017191A1 (it) * 2020-07-15 2022-01-15 Xbrane Biopharma Ab Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
PH19942A (en) 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
DE3428372A1 (de) 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
CH660302A5 (fr) 1984-10-17 1987-04-15 Debiopharm Sa Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
US5000886A (en) 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US4908210A (en) * 1988-10-28 1990-03-13 Eastman Kodak Company Lactylic salt tablet formulations and tablets
IL92344A0 (en) * 1989-01-04 1990-07-26 Gist Brocades Nv Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
US5208038A (en) * 1989-12-08 1993-05-04 Dow Corning Corporation Coacervated highly absorptive polymers

Also Published As

Publication number Publication date
US5503851A (en) 1996-04-02
EP0579347B1 (de) 1996-04-24
ATE137114T1 (de) 1996-05-15
HK1001470A1 (en) 1998-06-19
DK0579347T3 (da) 1996-08-12
EP0579347A1 (de) 1994-01-19
ES2085716T3 (es) 1996-06-01
DE4223169C1 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
DE59302329D1 (de) Mikroverkapselung wasserlöslicher Wirkstoffe
MA25858A1 (fr) Formulation d'insecticides en emulsion de type huileux
ATE196991T1 (de) Verfahren zur zubereitung von biologisch aktiven komponenten enthaltenden mikrospheren
ATE18511T1 (de) Verfahren zur zerstaeubungs-mikroeinkapselung und dazu verwendbare zusammensetzung.
MX9200875A (es) Compuestos de fluoroalquenilo y su uso como repelentes de pestes.
DE59304216D1 (de) Desodorierende kosmetische mittel mit einem gehalt an fettsäuren
HUT46516A (en) Insecticides comprising (+)1r-trans-2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylic acid-2,3,5,6-tetrafluorobenzyl ester and process for producing the active ingredient
RU93045143A (ru) Антибактериальная противобляшковая оральная композиция
DE69315026T2 (de) Verfahren zur Herstellung einer Zubereitung von Mikrosphären mit verzögerter Freigabe
ES2055292T3 (es) Procedimiento de microencapsulacion.
DE69423225D1 (de) Alpha sulfonierte methyl- oder ethylfettsäureestersalze und anionische oberflächenaktive mittel enthaltende flüssigwaschmittelzusammensetzungen
KR960705538A (ko) 수중유형 화장재료용 조성물(oil-in-water cosmetic composition)
DE69112914T2 (de) Herstellungsverfahren von Mikrokugeln.
ATE150075T1 (de) Detergenzusammensetzung
DE69026935D1 (de) Verbessertes Träger- und Freisetzungssystem von Riechstoffen für die Wäschebehandlung
ATE184059T1 (de) Verfahren und einrichtung zum parfümieren von wäsche
FR2721800B1 (fr) Nouveaux concentres emulsionnables renfermant un u plussieurs pesticides
DE68918923D1 (de) Stabile Emulsionsformulierungen von wasserunlöslichen organischen Pestiziden.
DE69227803D1 (de) Pyrethroide Ester des 1,3,4,5,6,7-Hexahydro-1,3-dioxol 2H-isoindol-2-yl Methylalkohols, Verfahren zu ihrer Herstellung und ihre Anwendung als Pestizide
ATE45855T1 (de) Insektizid wirksames mittel zur bekaempfung von textilschaedlingen.
DE69414487T2 (de) 2,2-Dimethyl-3-(3,3,3-Trifluor-1-Propenyl) Cyclopropancarbonsäureesterderivate, ihre Herstellung und ihre Verwendung als Pestizide
DE69230793T2 (de) Deodorant enthaltend eine O/W Emulsion und eine Parfummikrokapseln enthaltende Phase, und Verfahren zu ihrer Herstellung
DE69221214D1 (de) Polymer Latice von Estern von (meth) Acrylsäure und Vinylestern von verzweigter Karboxylsäure
PT963394E (pt) Solucoes de resina de poliester de impregnacao e de recobrimento e sua utilizacao
RU96113348A (ru) Гербицидная композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FERRING GMBH, 24109 KIEL, DE